Top compounds associated with response to IRX4


Feature Type Standardized
Nominal ANOVA
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.081 0.02
mRNA Sunitinib FIMM pan-cancer AAC 0.4 0.02
mRNA Gefitinib FIMM pan-cancer AAC 0.36 0.03
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC -0.18 0.03
mRNA phenformin GDSC1000 pan-cancer AAC 0.073 0.03
mRNA ATRA GDSC1000 pan-cancer AAC 0.079 0.03
mRNA myricetin CTRPv2 pan-cancer AAC 0.085 0.03
mRNA AMG-706 FIMM pan-cancer AAC 0.35 0.03
mRNA linifanib CTRPv2 pan-cancer AAC 0.079 0.04
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.069 0.04
Download CSV